Pharmaceutical Technology

FEBRUARY 16, 2023

This is said to be essential to determine in the clinic the complete spectrum of treatment effects, including immuno-oncology. It enables quick evaluation of a patient tumour response to a range of cancer drug modalities within 14 days of obtaining harvested samples of tumour cells.

Drug Development 96

Drug Development Communication 96

Pharmaceutical Technology

JANUARY 11, 2023

AbbVie has collaborated with Anima Biotech for the discovery and development of mRNA biology modulators against three oncology and immunology targets. The collaboration will use the mRNA Lightning platform from Anima and AbbVie’s oncology and immunology expertise to discover new mRNA biology modulators against the targets.

Communication 59

Communication 59

Quality Matters

OCTOBER 24, 2023

Based on an analysis by USP’s Medicine Supply Map team of 20 of the most essential oncology medicines – including four already in shortage – “there are several essential cancer medications that are vulnerable to future drug shortages,” Raghavendran said. These and other recommendations are outlined in a recent USP policy position paper. “We

Chemotherapy 64

Chemotherapy Hospitals 64

pharmaphorum

NOVEMBER 20, 2020

Gordon joins Prescient with more than 15 years of dedicated oncology experience in market research and competitive intelligence. Priya has co-authored several peer-reviewed scientific articles and industry-relevant white papers. Prior to joining Prescient, she served as a subject matter expert and trusted client advisor.

Medical Schools 69

Medical Schools 69

Pharmaceutical Technology

DECEMBER 14, 2022

In September, Merck and Guardant Health expanded their partnership to expedite the development of precision oncology therapeutics. By downloading this Whitepaper, you acknowledge that we may share your information with our white paper partners/sponsors who may contact you directly with information on their products and services.

Communication 52

Communication 52

Pharma Marketing Network

JULY 21, 2023

Some relevant groups to join include: Pharmaceutical Research and Manufacturers of America (PhRMA), Biotechnology Innovation Organization (BIO), and American Society of Clinical Oncology (ASCO). Be sure to post content that is relevant to the pharmaceutical industry and that is interesting and informative to your target audience.

Drug Development 52

Drug Development 52

pharmaphorum

SEPTEMBER 1, 2021

The new Cancer Care in Europe: Recovering from COVID-19 Disruption white paper assesses the disruption to patient care and the changes physicians implemented during the acute phase of the pandemic, with a focus on the way in which treatment strategies were altered.

112

112

pharmaphorum

JUNE 1, 2022

To improve outcomes for cancer patients and take advantage of the ground-breaking scientific and technological progress made in oncology prevention, diagnosis, therapy and care over recent years, it is of crucial importance to ensure all patients with cancer have an ongoing dialogue with the healthcare team. Finding out what patients want.

Pharmaceutical Companies 59

Pharmaceutical Companies Pharmaceutical Companies 59

pharmaphorum

SEPTEMBER 13, 2022

Noticing a pattern in the lymph nodes and spleen that indicated the appearance of disease, he published his findings in a paper entitled, ‘On Some Morbid Appearances of the Absorbent Glands and Spleen’. 1847 – Virchow links tumours and white blood cells. 1844 – First reported case of multiple myeloma.

Chemotherapy 98

Chemotherapy Immunity Immunization Documentation 98

pharmaphorum

JUNE 29, 2022

There’s no reason to suppose that the innovative launches coming in from 2020 have suddenly become less innovative and significant in terms of commercial potential; most launches are entering the same types of therapy area – oncology, immunology and rare diseases – as before the pandemic, and the unmet need in these areas remains high.

HIV Treatment and Prevention Agents 59

HIV Treatment and Prevention Agents Vaccines Pharmaceutical Companies Pharmaceutical Companies 59

pharmaphorum

OCTOBER 4, 2022

During the first stage of the initiative, more than 2,000 research papers were published, 49 clinical trials were carried out, and more than 30 patents were filed through the support of the US National Cancer Institute (NCI). These datasets are critical as a means to identify how molecular information affects clinical outcomes.”

Documentation 105

Documentation HIPAA Data Entry 105

pharmaphorum

JANUARY 14, 2021

As interactive time with HCPs is likely to be scarce, companies need to be even more ruthless in prioritising content and in deciding what content to generate in the first instance – for example, in Real World Evidence, as outlined in IQVIA’s white paper, ‘Excellent Launches are winning the Evidence battle’ CNS (re) emerges.

Biosimilars 71

Biosimilars Pharmaceutical Companies Pharmaceutical Companies Labelling 71

Eye on FDA

NOVEMBER 18, 2021

Two recent white papers – one by Friends of Cancer Research and one by the Institute for Clinical and Economic Review (ICER) have outlined suggestions for reform to the accelerated approval program designed to make it more transparent and consistent.

Communication 57

Communication Pharmaceutical Companies Pharmaceutical Companies 57

The Physician Pharmacist

SEPTEMBER 26, 2023

I met, you know, hundreds of people within the first week, I was introduced into medicine, I had it, you know, I got a white coat. But those things are, while important are not, you know, objective, if you're a program director, like I imagined that it would be nice to just look at the paper and say, Okay, this number sounds good.

Medical Schools 52

Medical Schools Communication Hospitals 52

RX Note

FEBRUARY 23, 2023

Drug Complaint - Actions to be taken Drug Recall - A brief overview Sterile and Nonsterile Manufacturing & Prepacking Extemporaneous Formulation - Discussing on references, vehicle in extemporaneous formulations and alcohol in compounding Extemporaneous Preparation with Unknown Stability - Some recommendations Extemporaneous Compounding - Discussing (..)

HIV Treatment and Prevention Agents 75

HIV Treatment and Prevention Agents Community Pharmacies Labelling Chemotherapy 75

Pharmaceutical Technology

MARCH 17, 2023

Between 2012 and 2022, the number of oncology risk sharing agreements increased massively by 498%. Watt said risk sharing agreements in oncology made up almost 50% of all pharmaceutical risk sharing agreements, as per a GlobalData analysis. This may be because access to oncology drugs varies widely across the world, she added.

Communication 102

Communication Pharmaceutical Companies Pharmaceutical Companies 102

Pharmaceutical Technology

FEBRUARY 20, 2023

Meanwhile, in clinical trials with available race data, white participants account for 59% of trial subjects, more than the combined total for all other racial categories. participation of white subjects. In addition, safety oncology and immunotherapy, which is a focus area for Cerba Research has close ties to virology.

Vaccines 52

Vaccines Communication Immunity Immunization 52

Pharmaceutical Technology

APRIL 6, 2023

Notably, oncology is the leading therapeutic area, with the highest percentage of new clinical development year-on year compared to other CGT therapy areas, indicating a high level of unmet needs and increased industry investment in the space.

Communication 52

Communication 52

Pharmaceutical Technology

MARCH 8, 2023

Molecular science and technology firm Caris Life Sciences and Incyte have entered a strategic research collaboration to advance the latter’s oncology pipeline. The post Caris signs research partnership with Incyte for oncology pipeline appeared first on Pharmaceutical Technology. Please check your email to download the Whitepaper.

Communication 52

Communication 52

Pharmaceutical Technology

MARCH 9, 2023

Global biopharmaceutical firm UCB and Cancer Research UK have entered a multi-project partnership to advance two of the former’s oncology antibody candidates through clinical trials. It will combine Cancer Research UK’s oncology-focused translational research and clinical development capabilities and the antibody discovery expertise of UCB.

Communication 52

Communication Immunity Immunization Drug Development 52

Pharmaceutical Technology

MARCH 20, 2023

Oncology and cardiovascular therapies were relatively low with 132 and 118 trials respectively. To learn more about how Oximio is unlocking the clinical trial potential of Africa, download the specially commissioned white paper below. Nigeria was the next highest with 169, followed by 163 in Kenya, and 160 in Uganda.

Communication 52

Communication Diabetes Labelling 52

Pharmaceutical Technology

FEBRUARY 20, 2023

This white paper explores the roles immunohistochemistry (IHC), next-generation sequencing (NGS), and circulating tumour DNA (ctDNA) play in non-small cell lung cancer (NSCLC) precision medicine therapy development, and how they help healthcare providers determine the most effective treatment regimens for their patients.

Research Laboratories 52

Research Laboratories Drug Development Vaccines Communication 52

Pharmaceutical Technology

MARCH 20, 2023

We believe that this antibody is a valuable addition to our immuno-oncology portfolio, whether used alone or in combination with our personalised immunotherapies.” “The data presented by OncoC4 on their ONC-392 antibody indicate a differentiated safety profile and encouraging clinical activity in various types of tumours. “We

Compounding 98

Compounding Communication 98

Pharmaceutical Technology

MARCH 20, 2023

Aside from a very slight rise in funding for genetic disorder treatments, investors’ order of priorities remains unchanged – with oncology still far and away the most actively funded area of research. But the headline figures are concealing some rising trends. One significant growth area is the rise of genomics.

Vaccines 90

Vaccines Communication Hospitals 90

Pharmaceutical Technology

JANUARY 12, 2023

For more information about how Baxter BioPharma Solutions manufacturing expertise can support your project, dow nload the paper below. . Download this whitepaper to find out more about oncology trends and how Baxter’s oncology contract manufacturing facility in Halle, Germany, minimise the risk of cross contamination.

Packaging 52

Packaging Communication Vaccines 52

Pharmaceutical Technology

FEBRUARY 24, 2023

AstraZeneca Oncology R&D Biologics Engineering & Oncology Targeted Delivery senior vice-president Puja Sapra said: “We are excited by the opportunity to accelerate the development of CMG901, a potential new medicine for patients with Claudin18.2-expressing expressing cancers.

Communication 52

Communication 52

Pharmaceutical Technology

JANUARY 10, 2023

Last year, AstraZeneca acquired Neogene Therapeutics and announced a partnership with Huma Therapeutics within the oncology space. By downloading this Report, you acknowledge that we may share your information with our white paper partners/sponsors who may contact you directly with information on their products and services.

Communication 98

Communication 98

Pharmaceutical Technology

FEBRUARY 28, 2023

This licensing agreement will expand Chipscreen NewWay’s pipeline in the field of antibody drugs and immuno-oncology.” Chipscreen Biosciences CEO and president Dr Xianping Lu said: “Biocytogen’s YH008 has unique mechanisms and outstanding preclinical results.

Immunity 52

Immunity Immunization Communication Drug Development 52

Pharmaceutical Technology

DECEMBER 13, 2022

Koh is Chief Product Officer at Suvoda, a global clinical trial technology company that specialises in complex studies in therapeutic areas such as oncology, central nervous system (CNS), and rare disease.

Communication 104

Communication Drug Development 104

Pharmaceutical Technology

FEBRUARY 17, 2023

The non-binding draft guidance gives insight into the agency’s current outlook and recommendations for standard and expedited programs in oncology. The agency proposes that pharma move away from the common maximum tolerated dose (MTD) to trial designs that prioritise drug dosage optimisation at different stages.

Dosage 115

Dosage Clinical Pharmacology Pharmaceutical Companies Pharmaceutical Companies 115

Pharmaceutical Technology

FEBRUARY 28, 2023

Celnova Pharma is an Argentina-based pharmaceutical company that centres its work around rare diseases, oncology, central nervous system, diabetes and critical care. HRA RD’s new partnership will function to allow HRA RD to launch its rare disease products Ketoconazole HRA and Lysodren across Argentina, Chile and Peru.

Diabetes 52

Diabetes Communication Pharmaceutical Companies Pharmaceutical Companies 52

Pharmaceutical Technology

DECEMBER 6, 2022

Within that figure, GlobalData estimates that around 60% of pipeline HPAPIs are developed to target oncology. HPAPIs may now represent more than 30% of the drug development pipeline.

Drug Development 52

Drug Development Dosage Pharmaceutical Manufacturing Communication 52

Pharmaceutical Technology

JANUARY 25, 2023

Others, like Elevation Oncology and Fate Therapeutics , have announced similar plans. While it is only January, several companies have already announced cuts and layoffs this year. UK-based biotech ReNeuron announced plans to lay off 40% of its employees , and Cyteir Therapeutics will be firing 70% of its staff.

Communication 69

Communication 69

Pharmaceutical Technology

DECEMBER 22, 2022

The new joint procedure will launch in Q1 2025 for oncology medicines and other advanced therapy medicinal products and extend to orphan drugs in 2028. As part of the decision-making process, they may request further evidence. By 2030, JCAs will be carried out on all medicinal products with an EMA-issued MA.

Pharmaceutical Companies 52

Pharmaceutical Companies Pharmaceutical Companies Labelling Communication 52

Pharmaceutical Technology

APRIL 16, 2023

This is an exciting prospect: oncology, and immuno-therapy in particular, is a driving force behind biotech R&D, with new cancer therapies and molecules accounting for nearly 40% 1 of the industry’s development pipeline. model, download this white paper. To learn more about the Maggie autoinjector and the newer 5.0

Documentation 52

Documentation Communication Hospitals 52

Pharmaceutical Technology

MAY 9, 2023

The shared expertise and resources enables Cerba Research to broaden its services within cell and gene therapy, infectious disease and oncology and access new markets in North America, Asia and Africa, the sites of some of the most exciting growth in clinical trials.

Vaccines 52

Vaccines Process Improvement Communication 52